MED
Medifast, Inc.
NYSE · usd
Medifast, Inc. (MED) trades at $11.87 (-2.47%) as of 7:30:24 PM EDT on Oct 23, 2026, -0.42% over the past month. Market cap is $136.07M, with 7.3 days to cover in short interest.
Stock performance
How Medifast, Inc. (MED) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.47%
- 1W
- -0.08%
- 1M
- -0.42%
- YTD
- +11.14%
- 1Y
- -6.68%
- 52-wk range
- $9.22 – $13.45
Key statistics
Today's trading snapshot for MED: day range, open, previous close, volume and market cap.
- Day range
- $11.67 – $12.10
- Open
- $12.10
- Prev close
- $12.17
- Volume
- 110.31K
- Market cap
- $136.07M
- Shares out
- 11.18M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Medifast, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 0.43
- P/B
- 0.69
- P/FCF
- 33.92
- ROE
- -13.0%
- ROA
- -9.8%
- Debt/Equity
- 0.00
- Div yield
- 0.12%
As of Oct 22, 2026
8-K filings
Material corporate events Medifast, Inc. has disclosed to the SEC on Form 8-K.
- Business developmentsJul 17, 2026
On July 17, 2026 Medifast, Inc. issued a Press Release announcing the rebranding of OPTAVIA, the lifestyle brand and a wholly-owned subsidiary of the company, to Trilivy, a comprehensive metabolic health system.
- Executive leadershipJun 1, 2026
Effective as of May 29, 2026, Jason L. Groves, Esq., the Chief Legal Officer & Corporate Secretary of Medifast, Inc. (the "Company"), tendered his resignation from the Company. On May 31, 2026, Mr. Groves and the Company entered into a separation and release agreement (the "Separation Agreement") pursuant to which Mr. Groves will receive a one-time lump sum cash severance payment equal to one month of his annual base salary, less applicable taxes and withholdings.
- Executive leadershipMay 26, 2026
In connection with Mr. Johnson's appointment to Chief Executive Officer, Mr. Johnson entered into an offer letter with the Company providing for the following terms: (a) annual base salary of $600,000; (b) participation in the Company's bonus program with a target bonus equal to 100% of his base salary, with the actual payout to be based on company performance; and (c) Long Term Incentive target at 250% of his base salary, representing an approximate 69% increase in total compensation as compared to compensation for his prior role of President.
- Shareholder activismMar 20, 2026
On March 19, 2026, Medifast, Inc. (the "Company") and Steamboat Capital Partners LLC and certain of its related persons ("Steamboat") entered into a Cooperation Agreement (the "Cooperation Agreement"). Under the terms of the Cooperation Agreement, the Company agreed to nominate the following persons for election to the Board of Directors of the Company (the "Board") at the 2026 Annual Meeting of Stockholders of the Company (the "2026 Annual Meeting"): Daniel R. Chard; Elizabeth A. Geary; Parsa Kiai; Jeffrey Rose; Scott Schlackman; Andrea B. Thomas; and Ming Xian.
- Executive leadershipJan 5, 2026
On December 30, 2025, Medifast, Inc. (the "Company") and Anthony Tyree, a named executive officer of the Company and Chief Business Operations Officer, agreed that Mr. Tyree will depart from his position as Chief Business Operations Officer and any and all other positions he holds as an officer or employee of the Company, effective December 31, 2025.
Dividend history and stock splits
Medifast, Inc.'s recent dividend payments and stock splits.
Dividends
- $1.65ex-div Sep 18, 2023
- $1.65ex-div Jun 26, 2023
- $1.65ex-div Mar 27, 2023
- $1.64ex-div Dec 19, 2022
Splits
No recent splits.
MED short interest
How heavily MED is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.3
- Short interest
- 1.05M
- Avg volume
- 144.28K
As of · reported to FINRA twice monthly.
MED news
The latest news and headlines about Medifast, Inc. (MED).
- Medifast Q3 Earnings on the Horizon: Key Insights for InvestorsnegativeZacks Investment Research· Oct 23, 2026
- Best Momentum Stocks to Buy for October 14thpositiveZacks Investment Research· Oct 14, 2026
- New Strong Buy Stocks for October 14thpositiveZacks Investment Research· Oct 14, 2026
- Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes?negativeZacks Investment Research· Oct 13, 2026
- Can Hormel Foods Tackle Input Costs With Pricing and Efficiency?neutralZacks Investment Research· Oct 7, 2026
Frequently asked questions
What is the Medifast, Inc. (MED) stock price today?
Medifast, Inc. (MED) is trading at $11.87 (-2.47% on the day) as of 7:30:24 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Medifast, Inc.?
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life.
What is the short interest in MED?
As of Sep 30, 2026, MED has 1.05M shares short and 7.3 days to cover.
Does Medifast, Inc. (MED) pay a dividend?
Yes. Medifast, Inc. (MED)'s most recent dividend was $1.65 per share, with an ex-dividend date of Sep 18, 2023. Full MED dividend history is available from the Massive API.
What exchange is MED listed on?
Medifast, Inc. (MED) trades on NYSE in USD, in the MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS industry.
Build with AI
Build an analysis of MED with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a MED analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.